Allworth Financial LP Enanta Pharmaceuticals Inc Transaction History

Allworth Financial LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$10.08 - $17.46 $866 - $1,501	86 New	86 $1,000
Q3 2023 Oct 31, 2023	BUY	$11.09 - $22.13 $232 - $464	21 Added 91.3%	44 $0
Q2 2023 Jul 18, 2023	BUY	$20.68 - $39.85 $268 - $518	13 Added 130.0%	23 $0
Q1 2023 Apr 18, 2023	BUY	$38.82 - $54.59 $388 - $545	10 New	10 $0
Q2 2022 Jul 13, 2022	SELL	$38.13 - $76.93 $190 - $384	-5 Closed	0 $0
Q1 2022 Apr 22, 2022	BUY	$56.06 - $74.11 $280 - $370	5 New	5 $0

109

21.2M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $107M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.